Journal of Pharmacological Sciences · 2013 · 56 citations · 30 references
Life SciencesOncologyPharmacologyApoptosisCell SignalingMolecular OncologyApoptosis In CancerApoptosis RegulationApoptotic Signal TransductionApoptotic SignalingCell DeathNeuronal Cell DeathApoptosis Signaling In CancerApoptotic Signaling In CancerApoptotic Signaling PathwaysGlial Cell ApoptosisNf-kappa B-mediated Anti-apoptotic SignalingNf-κb Signaling
Aggressive tumor growth and diffuse tissue invasion are hallmarks of malignant glioma. Embelin is an active compound identified as a novel XIAP inhibitor from the Embelia ribes that exhibits various medicinal effects including anti-inflammatory and anti-cancer activities. In the present study, we investigated whether embelin could have a therapeutic effect in glioma. We found that embelin suppressed proliferation of human glioma cells, but not in normal immortalized human astrocytes. In addition, embelin induced apoptosis in human glioma cells by inhibiting NF-κB, which is a crucial transcription factor associated with several human diseases including cancer and controls multiple genes involved in tumor progression such as cell proliferation and survival. Intriguingly, embelin had no inhibitory effect on XIAP in glioma cells even though discovered as an XIAP inhibitor, but instead inhibited NF-κB activity by reducing nuclear translocation of p65 through decreasing phosphorylation and proteasomal degradation of IκBα in glioma cells. Furthermore, p65 overexpression decreased embelin-induced apoptosis in glioma cells. Taken together these results indicate that embelin could be a potent novel therapeutic modality for glioma via blocking cancer cell proliferation and inducing apoptosis by inhibiting NF-κB activity.
30
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2012 · 10.7K citations · Full text
Zaneta Nikolovska‐Coleska, Liang Xu, Zengjian Hu et al. · Journal of Medicinal Chemistry · 2004 · 342 citations · Full text
Pharmacy, Oncology, Pharmacology +16
Cancer Statistics in Korea: Incidence, Mortality and Survival in 2006-2007
Kyu‐Won Jung, Sohee Park, Hyun-Joo Kong et al. · Journal of Korean Medical Science · 2010 · 297 citations · Full text
Molecular Basis of Nuclear Factor-κB Activation by <i>Astrocyte Elevated Gene-1</i>
Devanand Sarkar, Eun Sook Park, Luni Emdad et al. · Cancer Research · 2008 · 226 citations